Applied Therapeutics Inc (APLT)
$8.86
Live
Performance
- $8.70$9.00$8.86
1.81%
Downside
Day's Volatility :3.33%
Upside
1.56%
- $1.79$9.39$8.86
79.8%
Downside
52 Weeks Volatility :80.94%
Upside
5.64%
Returns
| Period | Applied Therapeutics Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | 76.03% | 3.6% | 0.0% |
6 Months | 103.17% | 10.2% | 0.0% |
1 Year | 258.4% | 19.6% | 0.0% |
3 Years | -42.89% | 16.8% | -23.0% |
Highlights
Market Capitalization | 991.1M |
Book Value | $0.63 |
Earnings Per Share (EPS) | -1.43 |
Wall Street Target Price | 12.8 |
Profit Margin | 0.0% |
Operating Margin TTM | -14194.44% |
Return On Assets TTM | -56.9% |
Return On Equity TTM | -473.39% |
Revenue TTM | -333.0K |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | -98.2% |
Gross Profit TTM | 0.0 |
EBITDA | -78.0M |
Diluted Eps TTM | -1.43 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.96 |
EPS Estimate Next Year | -0.42 |
EPS Estimate Current Quarter | -0.16 |
EPS Estimate Next Quarter | -0.21 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 44.47%
Technicals Summary
Sell
Neutral
Buy
Applied Therapeutics Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Applied Therapeutics Inc | 16.67% | 103.17% | 258.4% | -42.89% | -56.57% |
 Regeneron Pharmaceuticals, Inc. | -9.28% | 10.06% | 24.53% | 74.0% | 232.45% |
 Novo Nordisk A/s | -4.54% | -5.72% | 21.59% | 126.2% | 349.01% |
 Alnylam Pharmaceuticals, Inc. | 8.87% | 102.98% | 82.67% | 44.83% | 241.09% |
 Vertex Pharmaceuticals Incorporated | 5.0% | 20.77% | 31.37% | 158.16% | 163.17% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Applied Therapeutics Inc | NA | NA | NA | -0.96 | -4.73 | -0.57 | NA | 0.63 |
Regeneron Pharmaceuticals, Inc. | 26.41 | 26.41 | 1.37 | 44.9 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 40.21 | 40.21 | 1.81 | 3.36 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.42 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.59 | 0.18 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Applied Therapeutics Inc | Buy | $991.1M | -56.57% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $110.0B | 232.45% | 26.41 | 32.04% |
Novo Nordisk A/s | Buy | $529.8B | 349.01% | 40.21 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $38.1B | 241.09% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $128.7B | 163.17% | 32.84 | -4.74% |
Insights on Applied Therapeutics Inc
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 44.8% return, outperforming this stock by 87.7%
Institutional Holdings
Franklin Resources Inc
8.89%VR Adviser, LLC
8.31%Perceptive Advisors LLC
6.97%HHG PLC
6.66%BlackRock Inc
5.72%Propel Bio Management LLC
5.72%
Company Information
applied therapeutics, inc. is a hospital and health care company located in 3104 cherry palm dr, tampa, fl, united states.
Organization | Applied Therapeutics Inc |
Employees | 31 |
CEO | Dr. Shoshana Shendelman Ph.D. |
Industry | Biotechnology |
Discover More
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$8.86
-1.12%
Invesco Bulletshares 2025 Hi
$8.86
-1.12%
Schwab International Dividend Equity Etf
$8.86
-1.12%
Blockchain Coinvestors Acquisition Corp.
$8.86
-1.12%
Allgiant Travel Company
$8.86
-1.12%
Rogers Corp
$8.86
-1.12%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$8.86
-1.12%
Iheartmedia
$8.86
-1.12%
Lightpath Technologies Inc
$8.86
-1.12%